44.96 (-%)
As of Jul 31, 2024
Source:
Cerevel Therapeutics Holdings, Inc is a clinical-stage biopharmaceutical company pursuing a targeted approach to neuroscience that combines a deep understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous system, or CNS, target receptor selective pharmacology to discover and design new therapies.
| Country | United States |
| Headquarters | cambridge, massachusetts |
| Phone Number | (844) 304-2048 |
| Industry | manufacturing |
| CEO | Ron Renaud |
| Website | www.cerevel.com |